About KELIX bio
KELIX bio is a company based in Dubai (United Arab Emirates) founded in 2020 by Alhadi Alwazir was acquired by Mubadala in March 2024. KELIX bio has raised $150 million across 3 funding rounds from investors including Mubadala, DPI and British International Investment. KELIX bio has completed 1 acquisition, including Pharmaceutical Institute.
- Headquarter Dubai, United Arab Emirates
- Founders Alhadi Alwazir
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of KELIX bio
KELIX bio has successfully raised a total of $150M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in KELIX bio
KELIX bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Mubadala, DPI and British International Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A premier African investment firm focused on high-growth businesses.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Sovereign wealth fund of United Arab Emirates
|
Locked | Locked | Locked |
Investor details for KELIX bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KELIX bio
KELIX bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pharmaceutical Institute.
Investment portfolio details for KELIX bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical Institute is engaged in producing generic medicines in Morocco.
|
Locked | Locked | 1988 | Locked |
Complete acquisition details for KELIX bio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - KELIX bio
Detailed financials for KELIX bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kelix Bio Comparisons
Peer comparison for KELIX bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KELIX bio
Detailed competitors of KELIX bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kelix Bio
Complete news archive for KELIX bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KELIX bio
KELIX bio was founded in 2020.
KELIX bio is headquartered in Dubai, United Arab Emirates. It is registered at Dubai, Dubai, United Arab Emirates.
KELIX bio is a funded company, having raised a total of $150M across 3 funding rounds to date.
KELIX bio was established in 2020 and is headquartered in Dubai, United Arab Emirates. Research and development efforts are directed toward the production of pharmaceuticals across various therapeutic domains. Operations in the biotechnology sector emphasize drug manufacturing processes. The company was co-founded by Alhadi Alwazir, with activities centered on advancing therapeutic solutions in this field.
KELIX bio has made 1 acquisition, including Pharmaceutical Institute.